177 related articles for article (PubMed ID: 34416509)
1. Quinazolinone dimers as a potential new class of safer Kv1 inhibitors: Overcoming hERG, sodium and calcium channel affinities.
Emam AM; Peigneur S; Depuydt AS; Ibrahim SM; Lopes Pinheiro-Junior E; El-Sadek M; Hendrickx L; Tytgat J; Kothayer H
Bioorg Chem; 2021 Oct; 115():105264. PubMed ID: 34416509
[TBL] [Abstract][Full Text] [Related]
2. Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of the voltage-gated potassium channels.
Zidar N; Žula A; Tomašič T; Rogers M; Kirby RW; Tytgat J; Peigneur S; Kikelj D; Ilaš J; Mašič LP
Eur J Med Chem; 2017 Oct; 139():232-241. PubMed ID: 28802123
[TBL] [Abstract][Full Text] [Related]
3. Expression of voltage-gated K+ channels in human atrium.
Bertaso F; Sharpe CC; Hendry BM; James AF
Basic Res Cardiol; 2002 Nov; 97(6):424-33. PubMed ID: 12395204
[TBL] [Abstract][Full Text] [Related]
4. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.
Peukert S; Brendel J; Pirard B; Brüggemann A; Below P; Kleemann HW; Hemmerle H; Schmidt W
J Med Chem; 2003 Feb; 46(4):486-98. PubMed ID: 12570371
[TBL] [Abstract][Full Text] [Related]
5. Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias.
Brendel J; Peukert S
Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):273-87. PubMed ID: 15326917
[TBL] [Abstract][Full Text] [Related]
6. AbeTx1 Is a Novel Sea Anemone Toxin with a Dual Mechanism of Action on Shaker-Type K⁺ Channels Activation.
B Orts DJ; Peigneur S; Silva-Gonçalves LC; Arcisio-Miranda M; P W Bicudo JE; Tytgat J
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30275388
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel.
Peukert S; Brendel J; Pirard B; Strübing C; Kleemann HW; Böhme T; Hemmerle H
Bioorg Med Chem Lett; 2004 Jun; 14(11):2823-7. PubMed ID: 15125940
[TBL] [Abstract][Full Text] [Related]
8. Voltage-gated K+ channels in adipogenic differentiation of bone marrow-derived human mesenchymal stem cells.
You MH; Song MS; Lee SK; Ryu PD; Lee SY; Kim DY
Acta Pharmacol Sin; 2013 Jan; 34(1):129-36. PubMed ID: 23222271
[TBL] [Abstract][Full Text] [Related]
9. GiTx1(β/κ-theraphotoxin-Gi1a), a novel toxin from the venom of Brazilian tarantula Grammostola iheringi (Mygalomorphae, Theraphosidae): Isolation, structural assessments and activity on voltage-gated ion channels.
Montandon GG; Cassoli JS; Peigneur S; Verano-Braga T; Santos DMD; Paiva ALB; Moraes ÉR; Kushmerick C; Borges MH; Richardson M; Pimenta AMC; Kjeldsen F; Diniz MRV; Tytgat J; Lima ME
Biochimie; 2020 Sep; 176():138-149. PubMed ID: 32717411
[TBL] [Abstract][Full Text] [Related]
10. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.
Baell JB; Gable RW; Harvey AJ; Toovey N; Herzog T; Hänsel W; Wulff H
J Med Chem; 2004 Apr; 47(9):2326-36. PubMed ID: 15084131
[TBL] [Abstract][Full Text] [Related]
11. Subtype-specific block of voltage-gated K
Leipold E; Ullrich F; Thiele M; Tietze AA; Terlau H; Imhof D; Heinemann SH
Biochem Biophys Res Commun; 2017 Jan; 482(4):1135-1140. PubMed ID: 27916464
[TBL] [Abstract][Full Text] [Related]
12. Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel.
Beshore DC; Liverton NJ; McIntyre CJ; Claiborne CF; Libby B; Culberson JC; Salata JJ; Regan CP; Lynch JJ; Kiss L; Spencer RH; Kane SA; White RB; Yeh S; Hartman GD; Dinsmore CJ
Bioorg Med Chem Lett; 2010 Apr; 20(8):2493-6. PubMed ID: 20304642
[TBL] [Abstract][Full Text] [Related]
13. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis involved in the blocking effect of antidepressant metergoline on C-type inactivation of Kv1.4 channel.
Bai HW; Eom S; Yeom HD; Nguyen KVA; Lee J; Sohn SO; Lee JH
Neuropharmacology; 2019 Mar; 146():65-73. PubMed ID: 30465811
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels.
Tao H; Chen JJ; Xiao YC; Wu YY; Su HB; Li D; Wang HY; Deng MC; Wang MC; Liu ZH; Liang SP
Biochemistry; 2013 Oct; 52(42):7439-48. PubMed ID: 24044413
[TBL] [Abstract][Full Text] [Related]
16. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
17. Expression of voltage-dependent K(+) channel genes in mesenteric artery smooth muscle cells.
Xu C; Lu Y; Tang G; Wang R
Am J Physiol; 1999 Nov; 277(5):G1055-63. PubMed ID: 10564112
[TBL] [Abstract][Full Text] [Related]
18. A new class of blockers of the voltage-gated potassium channel Kv1.3 via modification of the 4- or 7-position of khellinone.
Harvey AJ; Baell JB; Toovey N; Homerick D; Wulff H
J Med Chem; 2006 Feb; 49(4):1433-41. PubMed ID: 16480279
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Shaker-type potassium channels by hypoxia. Oxygen-sensitive K+ channels in PC12 cells.
Conforti L; Millhorn DE
Adv Exp Med Biol; 2000; 475():265-74. PubMed ID: 10849667
[TBL] [Abstract][Full Text] [Related]
20. New screening system for selective blockers of voltage-gated K(+) channels using recombinant cell lines dying upon single action potential.
Fujii M; Hayashi K; Ohya S; Yamamura H; Imaizumi Y
J Pharmacol Sci; 2013; 123(2):147-58. PubMed ID: 24096832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
